Ian Tolfree is a Principal at Emerald with a PhD in Theoretical Physics from Johns Hopkins University. He founded TBT Pharma Inc. and became an Executive in Residence at Columbia Technology Ventures in 2025.
At firms with a similar stage, sector and check size.


One email when Ian's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckIan Tolfree is a Principal at Emerald with a PhD in Theoretical Physics from Johns Hopkins University. He founded TBT Pharma Inc. and became an Executive in Residence at Columbia Technology Ventures in 2025.
Emerald Development Managers has not reported a check size. It invests at pre-seed, seed, series a.
A warm intro from a founder Emerald Development Managers backed works best. A short LinkedIn note with one line on traction is the next best route.
Manager at The Johns Hopkins University’s FastForward incubator; Principal at Emerald; Founder and CEO at TBT Pharma Inc.; Executive in Residence at Columbia Technology Ventures.
Last updated 2026-10-15. Is this you? Ask for a correction.